Review



3t3 l1 murine preadipocyte cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC 3t3 l1 murine preadipocyte cell line
    3t3 L1 Murine Preadipocyte Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 641 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hfl1+cells/HFL1/pm42316277-42-1-6
    Average 96 stars, based on 641 article reviews
    3t3 l1 murine preadipocyte cell line - by Bioz Stars, 2026-08
    96/100 stars

    Images



    Similar Products

    96
    ATCC 3t3 l1 murine preadipocyte cell line
    3t3 L1 Murine Preadipocyte Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hfl1+cells/HFL1/pm42316277-42-1-6
    Average 96 stars, based on 1 article reviews
    3t3 l1 murine preadipocyte cell line - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    94
    MedChemExpress hfl1 cells
    Biocompatibility, biodegradability, antibacterial efficacy and antioxidation activity of HP/HLS hydrogel powder. (a) Representative images and quantitative analysis of hemolysis test of different materials in HP/HLS hydrogel (n = 3) (mean ± SD; ns: no significant difference, **** P < 0.0001 vs negative group). (b) Quantitative analysis of MeT-5A and <t>HFL1</t> cells viability cultured with HP/HLS hydrogels for 24 h, 48 h and 72 h via CCK-8 assay. (c) In vivo degradation behaviors of HP/HLS hydrogel in rat after subcutaneous injection. Bar: 2.5 mm. (d) The representative images of S. aureus and E. coli colony units after different treatment. (e) Quantitative analysis of the corresponding numbers of S. aureus and E. coli colony units after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (f) Quantitative analysis of bacterial inhibition rate after different treatment. (n = 3) (mean ± SD; **** P < 0.001 vs control group). (g) The OD value of S. aureus and E. coli bacterial suspension at 600 nm after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (h) The CLSM images of RAW 264.7 cells. Nucleus were labeled by Hoechst 33,342. ROS labeled by DCFH-DA. (Scale Bar: 50 μm) (i) Quantitative analysis of relative level of DCFH-DA in CLSM images (n = 3) (mean ± SD; **** P < 0.001 vs LPS group).
    Hfl1 Cells, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hfl1+cells/CFHR1%2C+Human/pmc13255078-310-2-13
    Average 94 stars, based on 1 article reviews
    hfl1 cells - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    96
    ATCC hfl1 cells
    Biocompatibility, biodegradability, antibacterial efficacy and antioxidation activity of HP/HLS hydrogel powder. (a) Representative images and quantitative analysis of hemolysis test of different materials in HP/HLS hydrogel (n = 3) (mean ± SD; ns: no significant difference, **** P < 0.0001 vs negative group). (b) Quantitative analysis of MeT-5A and <t>HFL1</t> cells viability cultured with HP/HLS hydrogels for 24 h, 48 h and 72 h via CCK-8 assay. (c) In vivo degradation behaviors of HP/HLS hydrogel in rat after subcutaneous injection. Bar: 2.5 mm. (d) The representative images of S. aureus and E. coli colony units after different treatment. (e) Quantitative analysis of the corresponding numbers of S. aureus and E. coli colony units after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (f) Quantitative analysis of bacterial inhibition rate after different treatment. (n = 3) (mean ± SD; **** P < 0.001 vs control group). (g) The OD value of S. aureus and E. coli bacterial suspension at 600 nm after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (h) The CLSM images of RAW 264.7 cells. Nucleus were labeled by Hoechst 33,342. ROS labeled by DCFH-DA. (Scale Bar: 50 μm) (i) Quantitative analysis of relative level of DCFH-DA in CLSM images (n = 3) (mean ± SD; **** P < 0.001 vs LPS group).
    Hfl1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hfl1+cells/HFL1/pm42303350-37-0-6
    Average 96 stars, based on 1 article reviews
    hfl1 cells - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    ATCC hfl 1 cells
    Biocompatibility, biodegradability, antibacterial efficacy and antioxidation activity of HP/HLS hydrogel powder. (a) Representative images and quantitative analysis of hemolysis test of different materials in HP/HLS hydrogel (n = 3) (mean ± SD; ns: no significant difference, **** P < 0.0001 vs negative group). (b) Quantitative analysis of MeT-5A and <t>HFL1</t> cells viability cultured with HP/HLS hydrogels for 24 h, 48 h and 72 h via CCK-8 assay. (c) In vivo degradation behaviors of HP/HLS hydrogel in rat after subcutaneous injection. Bar: 2.5 mm. (d) The representative images of S. aureus and E. coli colony units after different treatment. (e) Quantitative analysis of the corresponding numbers of S. aureus and E. coli colony units after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (f) Quantitative analysis of bacterial inhibition rate after different treatment. (n = 3) (mean ± SD; **** P < 0.001 vs control group). (g) The OD value of S. aureus and E. coli bacterial suspension at 600 nm after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (h) The CLSM images of RAW 264.7 cells. Nucleus were labeled by Hoechst 33,342. ROS labeled by DCFH-DA. (Scale Bar: 50 μm) (i) Quantitative analysis of relative level of DCFH-DA in CLSM images (n = 3) (mean ± SD; **** P < 0.001 vs LPS group).
    Hfl 1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hfl1+cells/HFL1/pm42296933-205-0-5
    Average 96 stars, based on 1 article reviews
    hfl 1 cells - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    ATCC fetal lung fibroblast cell line hfl1
    Biocompatibility, biodegradability, antibacterial efficacy and antioxidation activity of HP/HLS hydrogel powder. (a) Representative images and quantitative analysis of hemolysis test of different materials in HP/HLS hydrogel (n = 3) (mean ± SD; ns: no significant difference, **** P < 0.0001 vs negative group). (b) Quantitative analysis of MeT-5A and <t>HFL1</t> cells viability cultured with HP/HLS hydrogels for 24 h, 48 h and 72 h via CCK-8 assay. (c) In vivo degradation behaviors of HP/HLS hydrogel in rat after subcutaneous injection. Bar: 2.5 mm. (d) The representative images of S. aureus and E. coli colony units after different treatment. (e) Quantitative analysis of the corresponding numbers of S. aureus and E. coli colony units after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (f) Quantitative analysis of bacterial inhibition rate after different treatment. (n = 3) (mean ± SD; **** P < 0.001 vs control group). (g) The OD value of S. aureus and E. coli bacterial suspension at 600 nm after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (h) The CLSM images of RAW 264.7 cells. Nucleus were labeled by Hoechst 33,342. ROS labeled by DCFH-DA. (Scale Bar: 50 μm) (i) Quantitative analysis of relative level of DCFH-DA in CLSM images (n = 3) (mean ± SD; **** P < 0.001 vs LPS group).
    Fetal Lung Fibroblast Cell Line Hfl1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hfl1+cells/HFL1/pm42091592-284-4-14
    Average 96 stars, based on 1 article reviews
    fetal lung fibroblast cell line hfl1 - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    ATCC human fetal lung fibroblast cell line
    Biocompatibility, biodegradability, antibacterial efficacy and antioxidation activity of HP/HLS hydrogel powder. (a) Representative images and quantitative analysis of hemolysis test of different materials in HP/HLS hydrogel (n = 3) (mean ± SD; ns: no significant difference, **** P < 0.0001 vs negative group). (b) Quantitative analysis of MeT-5A and <t>HFL1</t> cells viability cultured with HP/HLS hydrogels for 24 h, 48 h and 72 h via CCK-8 assay. (c) In vivo degradation behaviors of HP/HLS hydrogel in rat after subcutaneous injection. Bar: 2.5 mm. (d) The representative images of S. aureus and E. coli colony units after different treatment. (e) Quantitative analysis of the corresponding numbers of S. aureus and E. coli colony units after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (f) Quantitative analysis of bacterial inhibition rate after different treatment. (n = 3) (mean ± SD; **** P < 0.001 vs control group). (g) The OD value of S. aureus and E. coli bacterial suspension at 600 nm after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (h) The CLSM images of RAW 264.7 cells. Nucleus were labeled by Hoechst 33,342. ROS labeled by DCFH-DA. (Scale Bar: 50 μm) (i) Quantitative analysis of relative level of DCFH-DA in CLSM images (n = 3) (mean ± SD; **** P < 0.001 vs LPS group).
    Human Fetal Lung Fibroblast Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hfl1+cells/HFL1/pm41972725-39-11-23
    Average 96 stars, based on 1 article reviews
    human fetal lung fibroblast cell line - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    ATCC fox kidney cells
    Biocompatibility, biodegradability, antibacterial efficacy and antioxidation activity of HP/HLS hydrogel powder. (a) Representative images and quantitative analysis of hemolysis test of different materials in HP/HLS hydrogel (n = 3) (mean ± SD; ns: no significant difference, **** P < 0.0001 vs negative group). (b) Quantitative analysis of MeT-5A and <t>HFL1</t> cells viability cultured with HP/HLS hydrogels for 24 h, 48 h and 72 h via CCK-8 assay. (c) In vivo degradation behaviors of HP/HLS hydrogel in rat after subcutaneous injection. Bar: 2.5 mm. (d) The representative images of S. aureus and E. coli colony units after different treatment. (e) Quantitative analysis of the corresponding numbers of S. aureus and E. coli colony units after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (f) Quantitative analysis of bacterial inhibition rate after different treatment. (n = 3) (mean ± SD; **** P < 0.001 vs control group). (g) The OD value of S. aureus and E. coli bacterial suspension at 600 nm after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (h) The CLSM images of RAW 264.7 cells. Nucleus were labeled by Hoechst 33,342. ROS labeled by DCFH-DA. (Scale Bar: 50 μm) (i) Quantitative analysis of relative level of DCFH-DA in CLSM images (n = 3) (mean ± SD; **** P < 0.001 vs LPS group).
    Fox Kidney Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hfl1+cells/HFL1/pmc13056563-325-8-17
    Average 96 stars, based on 1 article reviews
    fox kidney cells - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    Image Search Results


    Biocompatibility, biodegradability, antibacterial efficacy and antioxidation activity of HP/HLS hydrogel powder. (a) Representative images and quantitative analysis of hemolysis test of different materials in HP/HLS hydrogel (n = 3) (mean ± SD; ns: no significant difference, **** P < 0.0001 vs negative group). (b) Quantitative analysis of MeT-5A and HFL1 cells viability cultured with HP/HLS hydrogels for 24 h, 48 h and 72 h via CCK-8 assay. (c) In vivo degradation behaviors of HP/HLS hydrogel in rat after subcutaneous injection. Bar: 2.5 mm. (d) The representative images of S. aureus and E. coli colony units after different treatment. (e) Quantitative analysis of the corresponding numbers of S. aureus and E. coli colony units after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (f) Quantitative analysis of bacterial inhibition rate after different treatment. (n = 3) (mean ± SD; **** P < 0.001 vs control group). (g) The OD value of S. aureus and E. coli bacterial suspension at 600 nm after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (h) The CLSM images of RAW 264.7 cells. Nucleus were labeled by Hoechst 33,342. ROS labeled by DCFH-DA. (Scale Bar: 50 μm) (i) Quantitative analysis of relative level of DCFH-DA in CLSM images (n = 3) (mean ± SD; **** P < 0.001 vs LPS group).

    Journal: Materials Today Bio

    Article Title: Sprayable asymmetric hydrogel prevents postoperative pleural adhesions via physical and biological dual therapy

    doi: 10.1016/j.mtbio.2026.103297

    Figure Lengend Snippet: Biocompatibility, biodegradability, antibacterial efficacy and antioxidation activity of HP/HLS hydrogel powder. (a) Representative images and quantitative analysis of hemolysis test of different materials in HP/HLS hydrogel (n = 3) (mean ± SD; ns: no significant difference, **** P < 0.0001 vs negative group). (b) Quantitative analysis of MeT-5A and HFL1 cells viability cultured with HP/HLS hydrogels for 24 h, 48 h and 72 h via CCK-8 assay. (c) In vivo degradation behaviors of HP/HLS hydrogel in rat after subcutaneous injection. Bar: 2.5 mm. (d) The representative images of S. aureus and E. coli colony units after different treatment. (e) Quantitative analysis of the corresponding numbers of S. aureus and E. coli colony units after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (f) Quantitative analysis of bacterial inhibition rate after different treatment. (n = 3) (mean ± SD; **** P < 0.001 vs control group). (g) The OD value of S. aureus and E. coli bacterial suspension at 600 nm after different treatment (n = 3) (mean ± SD; **** P < 0.001 vs control group). (h) The CLSM images of RAW 264.7 cells. Nucleus were labeled by Hoechst 33,342. ROS labeled by DCFH-DA. (Scale Bar: 50 μm) (i) Quantitative analysis of relative level of DCFH-DA in CLSM images (n = 3) (mean ± SD; **** P < 0.001 vs LPS group).

    Article Snippet: MeT-5A and HFL1 cells were treated with 5 ng/mL transforming growth factor-β1 (TGF-β1) (MedChemExpress, USA) for 24 h to induce fibrotic changes.

    Techniques: Activity Assay, Cell Culture, CCK-8 Assay, In Vivo, Injection, Control, Inhibition, Suspension, Labeling

    The efficacy of HP/L@HLS hydrogel was validated in vitro. (a) MeT-5A cells treated with HP/L@HLS hydrogel were subjected to immunofluorescence staining to determine fibrosis- and MMT-related protein expression. (b) The corresponding relative fluorescence intensity quantifications presented in the panel below (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs TGF-β group, # P < 0.05, ## P < 0.01, ### P < 0.001 vs indicated group). (c) Schematic diagram of MeT-5A cells treated with HP/L@HLS. (d) HFL1 cells treated with HP/L@HLS hydrogel were subjected to immunofluorescence staining to determine fibrosis-related protein expression. (e) The corresponding relative fluorescence intensity quantifications presented in the panel to the right (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs TGF-β group, # P < 0.05, ### P < 0.001 vs indicated group). (f) Schematic diagram of HFL1 cells treated with HP/L@HLS. (g) M1-type macrophages treated with HP/L@HLS hydrogel were subjected to ELISA to determine IL-1β secretion levels (n = 3) (mean ± SD; *** P < 0.001 vs M1 group, ## P < 0.01, ### P < 0.001 vs indicated group). (h) M1-type macrophages treated with HP/L@HLS hydrogel were subjected to ELISA to determine TNF-α secretion levels (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01 vs M1 group). (i) Abundance of IL-1β, IL-6, TNF-α, and CXCL9 in M1 macrophages after 24 h of HP/L@HLS hydrogel treatment (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs M1 group, # P < 0.05, ### P < 0.001 vs indicated group). (j) Abundance of TGF-β, PDGF, and CTGF in M2 macrophages after 24 h of HP/L@HLS hydrogel treatment (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs M1 group, # P < 0.05 vs indicated group). (k) Schematic diagram of Raw264.7 cells treated with HP/L@HLS.

    Journal: Materials Today Bio

    Article Title: Sprayable asymmetric hydrogel prevents postoperative pleural adhesions via physical and biological dual therapy

    doi: 10.1016/j.mtbio.2026.103297

    Figure Lengend Snippet: The efficacy of HP/L@HLS hydrogel was validated in vitro. (a) MeT-5A cells treated with HP/L@HLS hydrogel were subjected to immunofluorescence staining to determine fibrosis- and MMT-related protein expression. (b) The corresponding relative fluorescence intensity quantifications presented in the panel below (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs TGF-β group, # P < 0.05, ## P < 0.01, ### P < 0.001 vs indicated group). (c) Schematic diagram of MeT-5A cells treated with HP/L@HLS. (d) HFL1 cells treated with HP/L@HLS hydrogel were subjected to immunofluorescence staining to determine fibrosis-related protein expression. (e) The corresponding relative fluorescence intensity quantifications presented in the panel to the right (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs TGF-β group, # P < 0.05, ### P < 0.001 vs indicated group). (f) Schematic diagram of HFL1 cells treated with HP/L@HLS. (g) M1-type macrophages treated with HP/L@HLS hydrogel were subjected to ELISA to determine IL-1β secretion levels (n = 3) (mean ± SD; *** P < 0.001 vs M1 group, ## P < 0.01, ### P < 0.001 vs indicated group). (h) M1-type macrophages treated with HP/L@HLS hydrogel were subjected to ELISA to determine TNF-α secretion levels (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01 vs M1 group). (i) Abundance of IL-1β, IL-6, TNF-α, and CXCL9 in M1 macrophages after 24 h of HP/L@HLS hydrogel treatment (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs M1 group, # P < 0.05, ### P < 0.001 vs indicated group). (j) Abundance of TGF-β, PDGF, and CTGF in M2 macrophages after 24 h of HP/L@HLS hydrogel treatment (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs M1 group, # P < 0.05 vs indicated group). (k) Schematic diagram of Raw264.7 cells treated with HP/L@HLS.

    Article Snippet: MeT-5A and HFL1 cells were treated with 5 ng/mL transforming growth factor-β1 (TGF-β1) (MedChemExpress, USA) for 24 h to induce fibrotic changes.

    Techniques: In Vitro, Immunofluorescence, Staining, Expressing, Fluorescence, Enzyme-linked Immunosorbent Assay